During the past decade, Cancer Center of Kansas - El Dorado conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 228 clinical trials were completed, i.e. on average, 296.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 81 clinical trials were completed. i.e. 675% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Center of Kansas - El Dorado" #1 sponsor was "National Cancer Institute (NCI)" with 114 trials, followed by "Alliance for Clinical Trials in Oncology" with 97 trials sponsored, "SWOG Cancer Research Network" with 89 trials sponsored, "Eastern Cooperative Oncology Group" with 21 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Center of Kansas - El Dorado" #1 collaborator was "National Cancer Institute (NCI)" with 262 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Cancer and Leukemia Group B" with 15 trials as a collaborator, "NCIC Clinical Trials Group" with 15 trials as a collaborator and "Eastern Cooperative Oncology Group" with 12 trials as a collaborator. Other collaborators include 70 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Center of Kansas - El Dorado" are "Breast Cancer" (45 trials), "Lung Cancer" (24 trials), "Lymphoma" (22 trials), "Leukemia" (15 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials). Many other conditions were trialed in "Cancer Center of Kansas - El Dorado" in a lesser frequency.

Most popular intervention types in "Cancer Center of Kansas - El Dorado" are "Drug" (311 trials), "Other" (181 trials), "Biological" (136 trials), "Procedure" (60 trials) and "Radiation" (57 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (88 trials), "Quality-of-Life Assessment" (46 trials), "placebo" (36 trials), "Paclitaxel" (32 trials) and "Carboplatin" (23 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Center of Kansas - El Dorado" are 290 trials for "All" genders, 77 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Center of Kansas - El Dorado". undefined are not yet recruiting, 19 are recruiting, 91 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 230 completed trials in Cancer Center of Kansas - El Dorado, 1 suspended trials, and 30 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Center of Kansas - El Dorado, 19 "Phase 1" clinical trials were conducted, 199 "Phase 2" clinical trials and 154 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".